"Overall, the book provides a succinct blueprint for the field of cardio-oncology. It informs its readers of the ideology necessary to provide quality clinical care in this specific area of medicine and shapes the direction that the field of cardio-oncology will likely take as its importance continues to increase over the coming years." -©Doody’s Review Service, 2022, Joseph T Hale, MD MPH Candidate (East Tennessee State University Quillen College of Medicine) Doody's Score: 4 Stars!

• 1. The Cardio-Oncology ClinicPart I. Cardiovascular Disease Management Before Cancer TreatmentSection A. The A-to-Z Before Therapy2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy3. Chemotherapeutic Risks Before Cancer Therapy4. Radiation Therapy Risks Before Cancer Therapy5. Bone Marrow Transplantation Risks Before Cancer Therapy6. Surgical Risks Before Cancer TherapySection B. Cardiovascular Disease Prevention in Cancer Patients7. Cardiomyopathy/Heart Failure Prevention Before Cancer Therapy8. Vascular Disease Prevention Before Cancer Therapy9. Thromboembolic Disease Prevention Before Cancer Therapy10. Arrhythmia Prevention and Device Management Before Cancer Therapy11. Hypertension and Renal Disease Prevention Before Cancer Therapy12. Pulmonary Disease Prevention Before Cancer Therapy13. Cardiopulmonary Exercise for Prevention Before Cancer TherapyPart II. Cardiovascular Disease Management During Cancer TreatmentSection C. The A-to-Z Through Therapy14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy15. Cardiomyopathy/Heart Failure Myocarditis, and Takotsubo's During Cancer Therapy16. Structural Heart Disease17. Vascular Disease18. Thromboembolic Disease19. Arrhythmia, QTc Prolongation, and Device Management20. Hypertension and Renal Disease21. Pulmonary Disease22. Cardiovascular ImagingPart III. Cardiovascular Disease Management After Cancer TreatmentSection D. The A-to-Z After Therapy23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy24. Cancer Survivorship and Co-Morbidity Disease Risk25. Long-Term Complications of Chemotherapy26. Long-Term Complications of Radiation TherapySection E. Cardiovascular Disease in Cancer Survivors27. Cardiomyopathy/Heart Failure Prevention and Management28. Structureal Heart Disease Prevention and Management29. Vascular Disease Prevention and Management30. Thromboembolic Disease Prevention and Manageent31. Arrhythmia Prevention and Management32. Hypertension and Renal Failure Prevention and Management33. Pulmonary Disease Prevention and Management34. Cardiopulmonary RehabilitationSection F. Cardiovascular Disease Management in Specific Malignant Diseases35. Breast Cancer36. Uterine, Ovary, and Cervical Cancer37. Prostate and Testicular Cancer38. Renal and Urinary Bladder Cancer39. Lung Cancer40. Colorectal Cancer41. Esophageal and Gastric Cancer42. Hepatobiliary Carcinomas43. Pancreatic Cancer44. Melanoma45. Head-and-Neck Cancers46. Thyroid cancer47. Glioblastoma48. Bone and Soft Tissue Sarcomas49. Leukemias50. Lymphomas51. Multiple Myeloma and Cardiac Amyloidosis52. Carcinoid53. Cardiac MassesPart IV. Cancer Drugs54. Cancer Therapeutic Drug Guide

"Overall, the book provides a succinct blueprint for the field of cardio-oncology. It informs its readers of the ideology necessary to provide quality clinical care in this specific area of medicine and shapes the direction that the field of cardio-oncology will likely take as its importance continues to increase over the coming years." -©Doody’s Review Service, 2022, Joseph T Hale, MD MPH Candidate (East Tennessee State University Quillen College of Medicine) Doody's Score: 4 Stars!

• 1. The Cardio-Oncology ClinicPart I. Cardiovascular Disease Management Before Cancer TreatmentSection A. The A-to-Z Before Therapy2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy3. Chemotherapeutic Risks Before Cancer Therapy4. Radiation Therapy Risks Before Cancer Therapy5. Bone Marrow Transplantation Risks Before Cancer Therapy6. Surgical Risks Before Cancer TherapySection B. Cardiovascular Disease Prevention in Cancer Patients7. Cardiomyopathy/Heart Failure Prevention Before Cancer Therapy8. Vascular Disease Prevention Before Cancer Therapy9. Thromboembolic Disease Prevention Before Cancer Therapy10. Arrhythmia Prevention and Device Management Before Cancer Therapy11. Hypertension and Renal Disease Prevention Before Cancer Therapy12. Pulmonary Disease Prevention Before Cancer Therapy13. Cardiopulmonary Exercise for Prevention Before Cancer TherapyPart II. Cardiovascular Disease Management During Cancer TreatmentSection C. The A-to-Z Through Therapy14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy15. Cardiomyopathy/Heart Failure Myocarditis, and Takotsubo's During Cancer Therapy16. Structural Heart Disease17. Vascular Disease18. Thromboembolic Disease19. Arrhythmia, QTc Prolongation, and Device Management20. Hypertension and Renal Disease21. Pulmonary Disease22. Cardiovascular ImagingPart III. Cardiovascular Disease Management After Cancer TreatmentSection D. The A-to-Z After Therapy23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy24. Cancer Survivorship and Co-Morbidity Disease Risk25. Long-Term Complications of Chemotherapy26. Long-Term Complications of Radiation TherapySection E. Cardiovascular Disease in Cancer Survivors27. Cardiomyopathy/Heart Failure Prevention and Management28. Structureal Heart Disease Prevention and Management29. Vascular Disease Prevention and Management30. Thromboembolic Disease Prevention and Manageent31. Arrhythmia Prevention and Management32. Hypertension and Renal Failure Prevention and Management33. Pulmonary Disease Prevention and Management34. Cardiopulmonary RehabilitationSection F. Cardiovascular Disease Management in Specific Malignant Diseases35. Breast Cancer36. Uterine, Ovary, and Cervical Cancer37. Prostate and Testicular Cancer38. Renal and Urinary Bladder Cancer39. Lung Cancer40. Colorectal Cancer41. Esophageal and Gastric Cancer42. Hepatobiliary Carcinomas43. Pancreatic Cancer44. Melanoma45. Head-and-Neck Cancers46. Thyroid cancer47. Glioblastoma48. Bone and Soft Tissue Sarcomas49. Leukemias50. Lymphomas51. Multiple Myeloma and Cardiac Amyloidosis52. Carcinoid53. Cardiac MassesPart IV. Cancer Drugs54. Cancer Therapeutic Drug Guide

"Overall, the book provides a succinct blueprint for the field of cardio-oncology. It informs its readers of the ideology necessary to provide quality clinical care in this specific area of medicine and shapes the direction that the field of cardio-oncology will likely take as its importance continues to increase over the coming years." -©Doody’s Review Service, 2022, Joseph T Hale, MD MPH Candidate (East Tennessee State University Quillen College of Medicine) Doody's Score: 4 Stars!

• 1. The Cardio-Oncology ClinicPart I. Cardiovascular Disease Management Before Cancer TreatmentSection A. The A-to-Z Before Therapy2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy3. Chemotherapeutic Risks Before Cancer Therapy4. Radiation Therapy Risks Before Cancer Therapy5. Bone Marrow Transplantation Risks Before Cancer Therapy6. Surgical Risks Before Cancer TherapySection B. Cardiovascular Disease Prevention in Cancer Patients7. Cardiomyopathy/Heart Failure Prevention Before Cancer Therapy8. Vascular Disease Prevention Before Cancer Therapy9. Thromboembolic Disease Prevention Before Cancer Therapy10. Arrhythmia Prevention and Device Management Before Cancer Therapy11. Hypertension and Renal Disease Prevention Before Cancer Therapy12. Pulmonary Disease Prevention Before Cancer Therapy13. Cardiopulmonary Exercise for Prevention Before Cancer TherapyPart II. Cardiovascular Disease Management During Cancer TreatmentSection C. The A-to-Z Through Therapy14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy15. Cardiomyopathy/Heart Failure Myocarditis, and Takotsubo's During Cancer Therapy16. Structural Heart Disease17. Vascular Disease18. Thromboembolic Disease19. Arrhythmia, QTc Prolongation, and Device Management20. Hypertension and Renal Disease21. Pulmonary Disease22. Cardiovascular ImagingPart III. Cardiovascular Disease Management After Cancer TreatmentSection D. The A-to-Z After Therapy23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy24. Cancer Survivorship and Co-Morbidity Disease Risk25. Long-Term Complications of Chemotherapy26. Long-Term Complications of Radiation TherapySection E. Cardiovascular Disease in Cancer Survivors27. Cardiomyopathy/Heart Failure Prevention and Management28. Structureal Heart Disease Prevention and Management29. Vascular Disease Prevention and Management30. Thromboembolic Disease Prevention and Manageent31. Arrhythmia Prevention and Management32. Hypertension and Renal Failure Prevention and Management33. Pulmonary Disease Prevention and Management34. Cardiopulmonary RehabilitationSection F. Cardiovascular Disease Management in Specific Malignant Diseases35. Breast Cancer36. Uterine, Ovary, and Cervical Cancer37. Prostate and Testicular Cancer38. Renal and Urinary Bladder Cancer39. Lung Cancer40. Colorectal Cancer41. Esophageal and Gastric Cancer42. Hepatobiliary Carcinomas43. Pancreatic Cancer44. Melanoma45. Head-and-Neck Cancers46. Thyroid cancer47. Glioblastoma48. Bone and Soft Tissue Sarcomas49. Leukemias50. Lymphomas51. Multiple Myeloma and Cardiac Amyloidosis52. Carcinoid53. Cardiac MassesPart IV. Cancer Drugs54. Cancer Therapeutic Drug Guide